Astragalus polysaccharide can improve insulin sensitivity by inhibiting the expression of protein tyrosine phosphatase 1B (PTP1B), a potential therapeutic target of DM, in type 2 diabetic (T2D) rats [5]. Here, PTPN1 is linked to type 2 diabetes mellitus.